Misc Games is a game developer based in Stavanger – Norway, with several collaborators around the world. We make games for PC/Consoles. Misc Games aims at developing unique games for various niche markets. We treat developers like human beings and video games like art rather than toys. Everyone at Misc Games has a strong passionate for video games and that’s why we want to evolve the industry into something better. We want to develop games mostly for the more mature and educated gamers.

At Aivero we strive to bring AI to industrial robotics. We are a young and dynamic startup with offices in Norway and Denmark Aivero is a Scandinavian startup founded in 2017 with a mission to democratize automation by simplifying robotic control to the point where anyone can deploy and operate them. No more code, programming, or complex path planning—vision-guided robotics automates this too.

Vi leverer styringsløsninger som skal gi virksomheter økt lønnsomhet gjennom bedre styring og kontroll. Vår spesialitet er å forstå kunden sine utfordringer og raskt få på plass en løsning som gir resultater ved å koble forretningforståelse og teknologi. For mindre virksomheter leverer vi portal som kombinerer rapportløsninger med virksomhetskritisk styringsinformasjon. Sammen med den største aktøren innen bolig utvikler vi løsninger hvor vi kombinerer interne data med ekstern informasjon og kunstig intelligens.

HTTECH's mission is to support heavy industries on the way to sustainable development. HTTECH's vision: Contribute to solving environmental challenges for the established industry in a cost-efficient manner and produce nano-based materials for the future to transform waste into high-value products with high-demand. Build sustainable business in the space of circular economyHTTECH is a company with a solid competence in the field of high-temperature technologiesExpertise: R&D projects in the fields of Hydrogen and Solar Energetics, Energy Savings, Oil&Gas Industry, Computer ModelingMetallurgy & Chemical Engineering, Materials Science and International Business Development Industrial expertise

Secure Payment Transaction System with #1 Ranking Our App is integrated with the most secure payment gateways in the world. We use the most advanced encryption technology to ensure that your payment is safe and secure. We are the first to integrate local banks directly with < 1% transaction fee thanks to PSD2 License ( Card-Less Transactional Handshake )

ENVE leverer morgendagens datarom for sømløse og effektive transaksjoner. Ved blant annet automatisering av rapportgenerering og optimalisering av informasjonsflyt tilbyr vi våre kunder et markedsledende arbeidsverktøy for due diligence-prosesser og transaksjoner. ENVE skal gå i bresjen for å bidra til digitalisering og modernisering av transaksjonsmarkedet.

The Founder Institute is the world’s premier startup launch program for talented entrepreneurs. If you are up to the challenge, our comprehensive step-by-step program will give you the structure, mentor support, and network of entrepreneurs you need to start an enduring company. Based in Silicon Valley and with chapters across 60 countries, the Founder Institute's mission is to "Globalize Silicon Valley" and build sustainable startup ecosystems worldwide.

Bile duct cancer is an aggressive form of cancer with an extremely poor overall five-year survival rate of just 2-5 %. Classified as an orphan disease, annual incidence in Europe and the United States of 15-22,000 patients, and a significantly higher incidence in Asia, makes it a major player and the deadliest of the gastrointestinal cancers. Only a small number of patients are eligible for a complete surgical resection by local resection or liver transplantation, and more than 50% of these relapse. The vast majority are treated by gemcitabine-based palliative chemotherapy with a life expectancy of 11 months, and five-year survival rate of zero %. Thus, there is an urgent and unmet medical need to develop new and better treatment strategies for these patients. The innovations developed by Seald are a result of adopting a multidisciplinary approach to the diagnosis and treatment of bile duct cancer, based on extensive drug sensitivity assays on living cancer cells, molecular biomarkers, DNA sequencing, extensive bioinformatics analyses and zebrafish models. Sealds’s holistic approach is unique with possible modes of action that can be used on other solid cancers. Our technology includes drug repurposing and innovation on new medical substances, diagnostics and methodology. The stipulated pharma market globally is USD 2.1-4.2 billion, in addition to the markets for diagnostics and platform technology

Yetz is a new distribution platform for product lines such as insurance, electricity, telecom, and finance. At launch, we will offer both insurance and power. We utilize strong incentives towards our customers and partners to share the concept, by giving them an affiliate commission. Monthly payment is based on the turnover of customers they have referred. Two fully owned sister companies Yetz Strøm og Yetz Forsikring.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Nanook is a global movement of more than 2400 local travel experts committed to sharing amazing experiences and insider knowledge. Being a partner of Nanook not only require high quality, but we also have non-negotiable rules of local ownership and responsibility towards nature and local communities.

KOMENT utvikler og produserer opplevelsesbasert kommunikasjon. I KOMENT arbeider 25 kompetente medarbeidere med lang erfaring innen bl.a nettverksbygging, arrangement, media, markedsføring, sosiale medier, web og digitale utviklingsprosjekter, animasjon & design, sponsoring og events. Et komplett reise- og kommunikasjonsbyrå.

Vi tør å tenke nytt i en bransje som er preget av umoderne arbeidsformer, og kombinerer tung juridisk kompetanse med markedsledende teknologi. LIGL ble startet for å utfordre den konservative advokatbransjen, og bygger på tre grunnleggende prinsipper, kompetanse, kultur og teknologi – vårt DNA. Gjennom innovativ bruk av teknologi, en moderne forretningsmodell og et unikt arbeidsmiljø, vil vi skape et reelt, effektivt og eksklusivt alternativ til de største advokatfirmaene i Norge. Vi vet at dette vil og må ta tid, men vi vet også at det er denne veien bransjen vil utvikle seg – og vi ønsker å være i forkant. LIGL består av topp kvalifiserte forretningsadvokater med lang fartstid, solid faglig ekspertise og entusiasme for den jobben de gjør. Flere av firmaets advokater kommer fra ledende partnerstillinger i landets største advokatfirmaer. Kundene våre er norske og internasjonale virksomheter. Vi bistår alt fra gründervirksomheter i oppstart, til store selskaper med en lang historie å se tilbake på. Vi tar også oppdrag for privatpersoner innenfor utvalgte rettsområder. Firmaet leverer advokattjenester innen følgende fagområder: - Corporate, strategisk selskapsrettslig rådgivning - Rekonstruksjon & insolvens - Immaterialrett & teknologi - Fast eiendom - Skatt - Tvisteløsning Firmaets advokater er dyktige tverrfaglige forretningsadvokater, og firmaet tar derfor også oppdrag innenfor andre fagområder som naturlig leveres av et kompetent forretningsadvokatfirma, som arbeidsrett, kontraktsrett, entreprise etc.

Our mission is to create a thriving and evolving community of startups and creatives.DIGS is an innovation platform located in Trondheim, built on exchanges between members and partners who unite entrepreneurs, ‘makers’, and ‘doers’ from varied sectors. DIGS supports startup activities by providing an office environment and space for public activities, stimulating a culture of collaboration, sustainability, and mutual innovation through shared knowledge and experience. We participate in entrepreneurship networks across Norway, Europe, and internationally and aim to strengthen ties, stimulate the local community, and boost business development in and around the region of Trondheim. The idea of creating DIGS started with three enthusiastic people who wanted to make space for innovation in Trondheim. They started working on the idea in 2011 and acquired the space we are currently located in in the summer of 2013. The word DIGS means workplace and living space.

AYR AS er bygget opp av to avdelinger, henholdsvis Kommunikasjon og Infrastruktur.Kommunikasjon leverer ytelsesbaserte kommunikasjonstjenester og markedsføring. Vi har derfor et stort fokus på det digitale. I Infrastrukturavdelingen leverer vi de tradisjonelle IT-tjenestene men den grunnleggende idéen er at vi skal bruke den nye teknologien, herunder skyteknologi. Vi ønsker å gjøre IT enkelt og kombinert med at tjenestene vi leverer er tett knyttet til hverandre – gir det kundene ett kontaktpunkt. Teknologi kan både påvirke samfunnet og miljøet. Alle som jobber i AYR ønsker at teknologisk utvikling skal dytte samfunnet i riktig retning, hvor teknologi gjør at alle kan bidra og bli hørt. Vi bidrar derfor gjennom at 5% av konsernets overskudd fordeles mellom barne- og ungdomsarbeid innenfor teknologi og støttearbeid innen teknologi i utviklingsland.